Khunti K, Ruan Y, Davies J, Field BCT, et al. Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19. Diabetes Care 2022 Sep 8. pii: 147558. doi: 10.2337/dc22-0357.
PMID: 36074663